États-Unis · Plateformes & données · TipRanks

Alembic Wins USFDA Approval for OTC Olopatadine Eye Drops

Publié par TipRanks · États-Unis il y a 9 h

Alembic Pharmaceuticals Limited ( ($IN:APLLTD) ) has issued an announcement. Alembic Pharmaceuticals, a vertically integrated generic-drug manufacturer with ...

Lire l'article complet sur TipRanks Connectez-vous pour sauvegarder

MarketNews présente le titre et le résumé publiés par le média. L'article complet se lit sur le site de l'éditeur. (www.tipranks.com)

Alembic Wins USFDA Approval for OTC Olopatadine Eye Drops

À lire aussi

Ralliant Corporation Non-GAAP EPS of $0.93, revenue of $620M

These stocks have soared the most today after the Democrats trounced Trump

Neuronetics (NASDAQ:STIM) Releases Quarterly Earnings Results, Beats Expectations By $0.07 EPS

Novo Nordisk (NVO) Q3 2026 Earnings Call Transcript

Eversource Energy earnings on deck after Q2 miss, estimate cuts

10-year Treasury yield slides as traders mull over Democrats' midterm victories, oil prices drop

Alembic Wins USFDA Approval for OTC Olopatadine Eye Drops

Partager

À lire aussi

Ralliant Corporation Non-GAAP EPS of $0.93, revenue of $620M

These stocks have soared the most today after the Democrats trounced Trump

Neuronetics (NASDAQ:STIM) Releases Quarterly Earnings Results, Beats Expectations By $0.07 EPS

Novo Nordisk (NVO) Q3 2026 Earnings Call Transcript

Eversource Energy earnings on deck after Q2 miss, estimate cuts

10-year Treasury yield slides as traders mull over Democrats' midterm victories, oil prices drop